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Abstract 
Background: In patients with secondary hyperparathyroidism, the four glands are not uniformly enlarged; 
therefore, preoperative localization is difficult in comparison with primary hyperparathyroidism. The aim of 
this study was to compare the usefulness of 99mTc-sestamibi scintigraphy versus ultrasonography in the 
preoperative assessment of patients with secondary hyperparathyroidism. 
Methods: Between October 2008 and March 2012, 25 uremic patients with secondary hyperparathyroidism 
underwent 99mTc-sestamibi scintigraphy and high resolution ultrasonography before total or subtotal 
parathyroidectomy. We measured plasma concentration of intact parathyroid hormone (PTH), calcium, 
phosphorus, and alkaline phosphatase (ALP) before parathyroidectomy. 
Results: Sensitivity and positive predictive value (PPV), respectively, were 47.3% and 97.8% for MIBI 
scintigraphy, and 69.5% and 96.9% for ultrasonography. The sensitivity of combined techniques was 84.2%. 
There was a positive correlation between the parathyroid glands’ weight and serum calcium level, and positive 
MIBI scintigraphy and ultrasonography results. However, there was no correlation between the preoperative 
serum PTH, phosphorus, alkaline phosphatase (ALP), dialysis duration, and parathyroid glands’ weight.  
Conclusions: Ultrasonography is a reliable non-invasive localization tool. It has greater sensitivity in localizing 
parathyroid glands in secondary hyperparathyroidism than scintigraphy. 
© 2014 Tehran University of Medical Sciences. All rights reserved. 
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Introduction 
Hyperparathyriodism (HPT) is a situation in which the 
parathyroid hormone (PTH) is produced in increased 
levels and results in high serum calcium (Ca) level. 
HPT is classified into primary, secondary, and tertiary 
types, based on its underlying cause. 
HPT is called primary when the levels of Ca cannot 
produce a negative feedback on PTH secretion and 
result in high PTH production from the parathyroid 
glands. In secondary HPT, high PTH level is a result of 
the feedback of chronically low calcium levels due to 
chronic renal failure or malabsorption. In tertiary HPT 
the triggered parathyroid cells autonomously secrete 
PTH irrespective to Ca levels and can result in chronic 
hypercalcemia even after successful renal grafting (1). 
Despite the opinion of a number of researchers that 
there is no need for the glands to be localized, there is 
evidence that shows a 10%-30% recurrence and failure 
in total resection of pathologic parathyroid glands 
during surgery, which indicate the importance of 
parathyroid localization prior to surgery. It is notable 
that the experience of the surgeon and localization of 
the glands are the two most important parameters in a 
successful surgery. Till recently, exploration in the 
surgery field was the most used technique to localize 
the glands; however, in the era of minimally invasive 
techniques, the pre-surgery localization is more 
important than ever. This can decrease the surgery 
period and the side effects, and can presumably lower 
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the morbidity rate of the disease (2-7). 
There are different modalities which can be used to 
localize the glands, such as CT scan, MRI, Nucleic 
Imaging, and angiography. Ultrasound, however, is 
less invasive and more cost-effective than other 
methods, but its sensitivity is based on the operator's 
precision. For example, the parathyroid gland can be 
easily mistaken with a thyroid nodule or a cyst (8-10) 
One of the newest methods introduced is technetium 
scan. Technetium (99mTc) sestamibi (under the trade 
name of Cardiolite) is a pharmaceutical agent used in 
nuclear medicine imaging. The drug is a coordination 
complex of the radioisotope technetium-99m with the 
ligand methoxyisobutylisonitrile (MIBI). The generic 
drug became available late September 2008. A scan of 
a patient using MIBI is commonly known as a "MIBI 
scan" (11-12). It has been shown that parathyroid gland 
takes up 99mTc MIBI following an intravenous 
injection and the patient's neck is imaged with a 
gamma camera to show the location of all glands. A 
second image is obtained after washout time 
(approximately 2 hours), and the mitochondria in the 
oxyphil cells of the abnormal glands retaining the 
99mTc are seen with the gamma camera. This imaging 
method will detect 75 to 90% of abnormal parathyroid 
glands in primary hyperparathyroidism (13-14). 
However, there is no clear evidence of the benefits of 
this method in secondary HPT. As there are no 
estimates of comparison between this method and the 
conventional exploring method in our region, the aim 
of this study is to compare the MIBI scintigraphy and 
ultrasonography in preoperative localization of 
secondary hyperparathyroidism. 
Materials and Methods 
The present study was conducted on secondary HPT 
patients' referred to the surgery ward of Shariati 
Hospital, Tehran, Iran (a referral teaching hospital of 
Tehran University of Medical Sciences). Through 
convenient sampling, 25 patients were enrolled into the 
study. The demographic and serologic (PTH, Ca, and 
P) data were collected from the medical records and
inserted into a checklist. We evaluated each
parathyroid gland separately. Forasmuch as every
patient has 4 parathyroid glands on average, there were
100 glands to study. Patients with ectopic parathyroid
glands were excluded from the study. We analyzed the
results of MIBI scintigraphy and ultrasound for each
gland separately and compared them with surgical
localization as a gold standard. All patients underwent
parathyroid MIBI scintigraphy and neck ultrasound.
Each of the methods were performed by one single
operator and interpreted by a single radiologist.
Afterward, all patients underwent surgery and
exploration was performed. Bilateral neck exploration
was performed in all patients. All susceptible tissues
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were resected, weighted, and examined as a frozen 
section in the operation room by a single pathologist. 
The final positive results for parathyroid during surgery 
were considered as gold standard for the localization. 
All information was kept confidential and the patients 
signed consent forms. 
Parathyroid scintigraphy 
Dual phase scintigraphy scan (SS) was performed 
with a small field of view gamma camera (209 apex 
ELSCINT; General Electric; Milwaukee, WI) with a 
pinhole collimator. Moreover, 10 planar 
anteroposterior images (dynamic acquisition, Matrix 
128*128) were obtained immediately after intravenous 
injection of 555 µBq 99mTc-methoxyisobutylisonitrile, 
sestamibi (early phase), and 2 hours later (late phase). 
A static image was taken of the thorax and 
mediastinum (300 seconds, Matrix 128*128, parallel 
collimator) to search for ectopic glands. 
Ultrasonography 
The patients were scanned lying supine with a pillow 
beneath the shoulders to slightly hyperextend the neck. 
Gray-scale imaging was performed with a high-
frequency linear transducer (EUB-525 scanner; Hitachi, 
Japan). The study included longitudinal images 
extending from the carotid artery to midline and 
transverse images extending from the hyoid bone 
superiorly to the thoracic inlet inferiorly. An enlarged 
parathyroid gland on grey-scale imaging appeared as a 
hypoechoic or isoechoic (in few cases) nodule posterior 
or lateral to the thyroid lobe, but separated from it and 
not adherent to surrounding tissues, or within the thyroid 
parenchyma. Gray-scale imaging was supplemented by 
color and power Doppler imaging to look for feeding 
vessels and vascularity of suspected adenomas shown at 
initial gray-scale imaging. Color and power Doppler 
imaging commonly shows a characteristic extra-
thyroidal feeding vessel (typically a branch of the 
inferior thyroidal artery), which enters the parathyroid 
gland at one of the poles. Internal vascularity is also 
commonly seen in a peripheral distribution. 
Statistical methods 
The data were entered and analyzed by SPSS for 
Windows (version 20; SPSS Inc., Chicago, IL, USA). 
The Quantitative and qualitative data are expressed by 
mean ± SD and n (%), respectively. Statistical tests 
such as t-test, chi-square, and correlation were 
performed. For testing the sensitivity and specificity, 
ROC curve analysis was conducted. Statistical 
significance was considered as P-value < 0.05. 
Results 
At the end of the study, the information of all 100 
glands (25 patients) was analyzed, from which the male 
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to female ratio was 13/12. Their age ranged between 16 
to 72 years with mean age of 38 years. Mean Ca, P, 
AKP, and PTH were 10.41, 6.16, 526, and 1096 mg/dl, 
respectively (Table 1). 
Table 1. Patients’ characteristics and preoperative 
markers 
Age (years)  38 (16-72) 
Female to male ratio 13/12 
Preoperative markers (mean) 
Preoperative Calcium (mg/dl) 10.4 (10.1 ± 0.8) 
Phosphate (mg/dl) 6.16 (5.9 ± 0.7) 
Parathyroid hormone (ng/L) 1096 (850 ± 270) 
Alkaline phosphatase (IU/l) 526 (490 ± 120) 
Scintigraphy 
All patients underwent MIBI scintigraphy. MIBI 
scintigraphy was able to identify 45 parathyroid glands 
among 100 glands; therefore, MIBI scintigraphy had 
47.3% sensitivity, 80% specificity, and 97.8% positive 
predictive value in detecting the glands. 
Ultrasonography 
On the other hand, preoperative ultrasonography was 
able to localize 64 parathyroid glands. In comparison to 
our gold standard (surgery), ultrasound had 69.5% 
sensitivity, 60% specificity, and 96.9% PPV. 
When we analyzed both studies together, 
scintigraphy or ultrasonography localized 80 abnormal 
glands with 84.2% sensitivity, 80% specificity, and 
98.7% positive predictive value (Table 2). 
Table 2. Comparison between SS and US in secondary 
hyperparathyroidism 
Method Positive results TP FP FN PPV Sensitivity 
US 66 (66%) 64 2 31 96.9% 69.5% 
SS 46 (46%) 45 1 50 97.8% 47.3% 
US and SS 81 (81%) 80 1 15 98.7% 84.2% 
TP: True Positive; FP: False Positive; FN: False Negative; 
PPV: Positive Predictive Value; SS: Scintigraphy Scan; 
US: Ultrasonography 
Median weight of parathyroid glands in positive 
and negative localization ultrasonography was 1.6 gr 
(0.3-10) and 0.5 gr (0.3-3.6) which were significantly 
different in the two groups (P < 0.001). Mean Ca, P, 
ALP, and PTH in positive and negative 
ultrasonography were 9.7, 6.5 mg/dl, 682 IU/dl, and 
1067 ng/dl vs. 9.3, 6.4 mg/dl, 481.6 IU/dl, and 1104 
ng/dl, respectively, and did not have a significant 
difference (P = 0.15) (Table 3). 
Median weight of parathyroid glands in positive 
and negative localization MIBI scintigraphy was 1.35 
gr (0.3-10) and 0.5 gr (0.3-4) which were significantly 
different in the two groups (P < 0.001). Mean Ca, P, 
ALP, and PTH in positive and negative MIBI 
scintigraphy were 10.1, 6.3 mg/dl, 660.5 IU/dl, and 
1240.5 ng/dl vs. 9.8, 6.6 mg/dl, 500.7 IU/dl, and 1069 
ng/dl, respectively, and did not have a significant 
difference (P = 0.01) (Table 4). 
Correlation test was performed for parathyroid 
glands’ weight and serologic parameters, in which only 
Ca levels were significantly and positively correlated 
with parathyroid glands’ weight (R = 0.321, P = 0.002). 
Discussion 
The use of routine preoperative localization study in 
patients with secondary hyperparathyroidism remains 
controversial. There are many options to use for 
localization, like scintigraphy, ultrasonography, CT, 
and MRI. However, only scintigraphy and recently 
ultrasonography have been used routinely. Among 
them ultrasonography is more available and 
cost-effective; nevertheless, it is operator dependent. 
Scintigraphy is a functional study while 
ultrasonography is an anatomical modality. Using them 
together improves preoperative localization (14). 
In some recent studies, the usefulness of 
ultrasonography in primary hyperparathyroidism has 
been investigated. It has been shown that 
ultrasonography has as much sensitivity and specificity 
as scintigraphy in detecting parathyroid adenoma if 
performed by experienced radiologists (14). In our 
study, which was conducted between 2009 and 2012 on 
all included patients, MIBI scintigraphy and 
Table 3. Serum calcium, serum parathyroid hormone, and weight of parathyroid glands in patients with secondary 
hyperparathyroidism according to the results by ultrasonographic localization 
Parameters Negative sonogram Positive sonogram P 
Serum calcium (mg/dl) 9.3 (9 ± 0.7) 9.7 (9.8 ± 0.6) N/S 
Serum PTH (ng/L) 1104 (1150 ± 165) 1067 (1050 ± 130) N/S 
Weight of adenomas (gr) 0.5 (0.4 ± 0.2) 1.6 (1.3 ± 0.6) < 0.001 
Data shown are in median. NS, P > 0.05 by Student’s t-test 
Table 4. Serum calcium, serum parathyroid hormone, and weight of parathyroid glands in patients with secondary 
hyperparathyroidism according to results of scintigraphic localization 
Parameters Negative scintigram Positive scintigram P 
Serum calcium (mg/dl) 9.8 10.1 N/S 
Serum PTH (ng/L) 1069 1240 N/S 
Weight of adenomas 0.5 1.35 0.001 
Data shown are median. NS, P > 0.05 by Student’s t-test 
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ultrasonography were performed before surgery to 
localize the pathologic glands. Afterwards, all patients 
underwent bilateral neck exploration and total or 31/2 
parathyroidectomy. The results indicate that the scan 
and ultrasound had 47.3% and 69.5% sensitivity, 
respectively. The PPV reported in our study was 97.8% 
and 96.9% for scintigraphy and ultrasonography, 
respectively. The combination of the two techniques 
yielded sensitivity of 84.2% and PPV of 98.7%. There 
was a statistically significant difference between the 
diagnostic accuracy of ultrasonography, scintigraphy, 
and “ultrasonography plus scintigraphy” as shown via 
comparison between two proportion version 8. The 
combination of scintigraphy and ultrasonography 
enhanced sensitivity when compared with either 
technique alone. 
The sensitivity of ultrasound in our study was 
comparable to the studies of Ishibashi et al., Kasai et 
al., and Nishida et al (12,15,16). There are studies 
which demonstrate lower sensitivity compared to our 
study; this may be due to the sonologists’ experience 
and the difference between sensitivity of the units and 
the size of the glands. The MIBI scintigraphy 
sensitivity in our study was 47.3%, which was similar 
to the studies of Fuster et al., Papanikolaou et al., and 
Sukan et al. and was lower comparing to a few studies 
(17,18,19) The results of MIBI scintigraphy is 
dependent on several factors, such as the type of 
hyperplasia (nodular or diffuse), the grade of 
proliferation, and the amount of mitochondria 
contained oxyphill cells in the glands, the weight of the 
glands, age, serum levels of Ca, PTH, and vitamin D, 
existence of thyroid nodules, and recently discovered, 
the amount of gene amplification and translation of 
proliferating cell nuclear antigen (PCNA) (15-19). 
Regarding our study, the sensitivity of ultrasound is 
higher than MIBI scintigraphy and it seems that 
ultrasound by an experienced sonographist can be more 
reliable than MIBI scintigraphy in localizing the glands 
prior to surgery in secondary hyperparathyroid patients. 
Furthermore, if we combine these two modalities, the 
sensitivity increases to 84.2%. Early studies of 
Tc-sestamibi scanning in secondary 
hyperparathyroidism found that sensitivity was lower 
than 50%, indicating that imaging was of limited 
usefulness (20) However, these studies used double-
phase scanning. Subtraction scanning has provided 
better results (21) In a recent study evaluating 
simultaneous acquisition of images with two 
radionuclides (Tc-sestamibi and 123-iodine), a technique 
that is not affected by patient movements, the sensitivity 
for localizing parathyroid glands was 90% (2). 
MIBI is the current radionuclide procedure of 
choice for parathyroid localization. Although 
reasonably good results can be obtained with planar 
imaging, the use of pinhole collimation, and the 
performance of subtraction imaging and single-photon 
emission computed tomography (SPECT) improve the 
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accuracy of the test. The parathyroid glands can be 
found anywhere from the angle of the mandible to the 
base of the heart, and therefore, this entire region 
should be included in the field of view. MIBI is most 
sensitive for detecting parathyroid adenomas; 
therefore, it is less useful in patients with secondary 
hyperparathyroidism, where the predominant lesion is 
hyperplasia. Finally and most importantly, parathyroid 
scintigraphy is a localizing procedure, not a diagnostic 
procedure. It should, therefore, be reserved primarily 
for patients with documented primary 
hyperparathyroidism (15-21) As our study depicted, 
ultrasonography has almost 70% sensitivity that is 
much higher than the sensitivity of scintigraphy 
(47.3%). Since ultrasonography is easier to perform 
and more accessible than scintigraphy, it is logical that 
it be performed preoperatively in secondary 
hyperparathyroidism.  
In order to determine which factors may interfere 
the accuracy of ultrasonography and scintigraphy, we 
compared preoperative serum calcium level, serum 
intact PTH level, and parathyroid glands’ weight 
between those patients in which ultrasonography and 
scintigraphy correctly localized the glands vs. those 
undetected. Only glands weight was significantly 
correlated with localization study findings. 
Conclusion 
Our study demonstrated 47.3% sensitivity for MIBI 
scintigraphy and 69.5% for ultrasound. However, for 
better localization of the parathyroid glands, using both 
modalities at the same time is recommended. 
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